1. Home
  2. BMEA vs SJT Comparison

BMEA vs SJT Comparison

Compare BMEA & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • SJT
  • Stock Information
  • Founded
  • BMEA 2017
  • SJT 1980
  • Country
  • BMEA United States
  • SJT United States
  • Employees
  • BMEA N/A
  • SJT N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • SJT Oil & Gas Production
  • Sector
  • BMEA Health Care
  • SJT Energy
  • Exchange
  • BMEA Nasdaq
  • SJT Nasdaq
  • Market Cap
  • BMEA 153.3M
  • SJT 181.8M
  • IPO Year
  • BMEA 2021
  • SJT N/A
  • Fundamental
  • Price
  • BMEA $4.19
  • SJT $3.91
  • Analyst Decision
  • BMEA Buy
  • SJT
  • Analyst Count
  • BMEA 13
  • SJT 0
  • Target Price
  • BMEA $37.25
  • SJT N/A
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • SJT 241.1K
  • Earning Date
  • BMEA 10-29-2024
  • SJT 12-27-2024
  • Dividend Yield
  • BMEA N/A
  • SJT 3.17%
  • EPS Growth
  • BMEA N/A
  • SJT N/A
  • EPS
  • BMEA N/A
  • SJT 0.19
  • Revenue
  • BMEA N/A
  • SJT $11,031,594.00
  • Revenue This Year
  • BMEA N/A
  • SJT N/A
  • Revenue Next Year
  • BMEA N/A
  • SJT N/A
  • P/E Ratio
  • BMEA N/A
  • SJT $20.57
  • Revenue Growth
  • BMEA N/A
  • SJT N/A
  • 52 Week Low
  • BMEA $3.61
  • SJT $3.21
  • 52 Week High
  • BMEA $20.21
  • SJT $5.81
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 24.17
  • SJT 45.65
  • Support Level
  • BMEA $3.81
  • SJT $3.78
  • Resistance Level
  • BMEA $6.06
  • SJT $4.31
  • Average True Range (ATR)
  • BMEA 0.56
  • SJT 0.16
  • MACD
  • BMEA -0.14
  • SJT -0.04
  • Stochastic Oscillator
  • BMEA 7.40
  • SJT 28.33

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About SJT San Juan Basin Royalty Trust

San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.

Share on Social Networks: